News Image

Ovid Therapeutics to Host Investor and Media Event Thursday, June 12, 2025

Provided By GlobeNewswire

Last update: Jun 5, 2025

NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to developing medicines for brain conditions with significant unmet need, will host an investor and media event on Thursday, June 12, 2025, on the topic of applying Biomarkers in Epilepsy, including their strategic use to demonstrate the pharmacodynamic activity of the Company’s OV329 clinical development program. World-leading expert, Dr. Alexander Rotenberger will join company management to discuss the emerging use of a wide range of biomarkers for the study of anti-seizure medicines. The event will take place at Ovid’s headquarters in New York’s Hudson Yards from 9:30 to 10:30 am ET and will be webcast simultaneously.

Read more at globenewswire.com

OVID THERAPEUTICS INC

NASDAQ:OVID (7/22/2025, 8:00:02 PM)

After market: 0.6838 +0.01 (+2.23%)

0.6689

+0.06 (+10.49%)



Find more stocks in the Stock Screener

OVID Latest News and Analysis

Follow ChartMill for more